Omicron infection may increase risk of reinfection, study finds

Researchers at McMaster University have found that rather than conferring immunity against future infections, infection during the first Omicron wave of COVID left the seniors they studied much more vulnerable to reinfection during the second Omicron wave.

The surprising finding from a study of 750 vaccinated seniors in Ontario retirement homes and long-term care settings suggests the we don't understand how some Omicron variants can evade the immune system, according to Dawn Bowdish, an immunologist who holds the Canada Research Chair in Aging & Immunity.

There have been four major waves of Omicron infections in Ontario, Canada, and researchers found that being infected during the first wave, which was caused by the Omicron BA.1 and BA.2 variants, caused older adults to be more susceptible to infections in the third wave, which was caused by the Omicron BA.5 variant. Surprisingly, people who had had an infection with an early Omicron variant were much more susceptible to becoming reinfected than people who had never had an infection at all.

"This research highlights the need for continued vigilance and underscores the importance of ongoing preventive measures against COVID-19, says Bowdish, who is corresponding author of a study published today in eClinicalMedicine, an open-access journal published by The Lancet. "We must remain cautious and proactive in our approach to protecting public health."

Senior co-author Andrew Costa, an epidemiologist and associate professor in McMaster's Department of Health Research Methods, Evidence and Impact, says the findings should serve as a warning that we don't know how previous infections will impact susceptibility to the variants which are now in circulation.

These findings strongly suggest broader research is required to understand whether the wider population shares the same susceptibility as the seniors our group studied. Until we know more, we think it's smart for everyone to protect themselves."

Andrew Costa, epidemiologist and associate professor, McMaster's Department of Health Research Methods, Evidence and Impact

Long-term care residents are easier to study because COVID-19 infections were, until recently, monitored more closely, Bowdish explains, and while the results may or may not be the same among the wider population, it's important to learn more, and for everyone to consider a COVID vaccine booster this fall.

Though the researchers were not able to identify which Omicron variant a person had, all the initial infections occurred during the BA.1/BA.2 wave, and all the reinfections occurred during the summer of 2022 when the BA.5 variant was responsible for the vast majority of infections.

"We found that some individuals had normal immune responses after the first infection, while others had very low levels of protective antibodies, which we believe was one contributing factor to why they got reinfected," says Bowdish.

The researchers urge people not to assume immunity from a prior Omicron infection and to remain vigilant to prevent further spread of the virus.

She and Costa emphasize the urgency of considering COVID vaccine boosters this fall to safeguard against potential reinfections.

"Our current vaccine schedules are based on the assumption that having had an infection provides some level of protection to future infections, but our study shows that may not be true for all variants in all people," says Bowdish.

Despite the significance of the findings, Bowdish highlights some caveats. The study focused on an older adult population, many of whom were frailty and had chronic health conditions, and the results may not directly apply to younger individuals.

Source:
Journal reference:

Breznik, J. A., et al. (2023) Early Omicron infection is associated with increased reinfection risk in older adults in long-term care and retirement facilities. eClinicalMedicine. doi.org/10.1016/j.eclinm.2023.102148.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients